Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation-Reference-Cited by-同舟云学术

Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation

Published:2019-01-01 Issue:1 Volume:34 Page:250-263
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Xu Xi¹²,Ren Jie¹²,Ma Yinghe¹²,Liu Hongting¹,Rong Quanjin¹,Feng Yifan¹,Wang Yameng¹,Cheng Yu¹,Ge Ruijia³,Li Zhiyu¹²,Bian Jinlei¹²

Affiliation:

1. State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, People’s Republic of China;

2. Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of China;

3. The Madeira School, McLean, VA, USA

Funder

National Natural Science Foundation of China

National Science Foundation of Jiangsu Province of China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/14756366.2018.1480614

Reference59 articles.